Paper42957747PubMed
ASIC1a promotes liver fibrosis by inhibiting METTL3 SUMOylation.
Li ZH and 25 others. Acta Pharmacol Sin, 2026.
Cite this record
ConductScience Library. ASIC1a promotes liver fibrosis by inhibiting METTL3 SUMOylation. Papers, record 42957747. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42957747
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- ASIC1a promotes liver fibrosis by inhibiting METTL3 SUMOylation.
- Journal
- Acta Pharmacol Sin
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-30
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36990226 | Global burden of liver disease: 2023 update. | J Hepatol | 2023 | https://conductscience.org/library/papers/36990226 | PubMed |
| 2 | 39036382 | Cancer incidence and mortality in China, 2022. | J Natl Cancer Cent | 2024 | https://conductscience.org/library/papers/39036382 | PubMed |
| 3 | 33128017 | Molecular and cellular mechanisms of liver fibrosis and its regression. | Nat Rev Gastroenterol Hepatol | 2021 | https://conductscience.org/library/papers/33128017 | PubMed |
| 4 | 34621747 | Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34621747 | PubMed |
| 5 | 37400694 | Hepatic inflammatory responses in liver fibrosis. | Nat Rev Gastroenterol Hepatol | 2023 | https://conductscience.org/library/papers/37400694 | PubMed |
| 6 | 28487545 | Mechanisms of hepatic stellate cell activation. | Nat Rev Gastroenterol Hepatol | 2017 | https://conductscience.org/library/papers/28487545 | PubMed |
| 7 | 38987597 | Glutamate acts on acid-sensing ion channels to worsen ischaemic brain injury. | Nature | 2024 | https://conductscience.org/library/papers/38987597 | PubMed |
| 8 | 29513651 | Gating mechanisms of acid-sensing ion channels. | Nature | 2018 | https://conductscience.org/library/papers/29513651 | PubMed |
| 9 | 31903118 | ASIC1a induces synovial inflammation via the Ca2+/NFATc3/ RANTES pathway. | Theranostics | 2020 | https://conductscience.org/library/papers/31903118 | PubMed |
| 10 | 37820466 | Kaempferol attenuates carbon tetrachloride (CCl4)-induced hepatic fibrosis by promoting ASIC1a degradation and suppression of the ASIC1a-mediated ERS. | Phytomedicine | 2023 | https://conductscience.org/library/papers/37820466 | PubMed |
| 11 | 32949431 | ASIC1a regulates miR-350/SPRY2 by N6 -methyladenosine to promote liver fibrosis. | FASEB J | 2020 | https://conductscience.org/library/papers/32949431 | PubMed |
| 12 | 30291941 | ASIC1a promotes high glucose and PDGF-induced hepatic stellate cell activation by inducing autophagy through CaMKKβ/ERK signaling pathway. | Toxicol Lett | 2019 | https://conductscience.org/library/papers/30291941 | PubMed |
| 13 | 30938088 | PI3-kinase/Akt pathway-regulated membrane transportation of acid-sensing ion channel 1a/Calcium ion influx/endoplasmic reticulum stress activation on PDGF-induced HSC Activation. | J Cell Mol Med | 2019 | https://conductscience.org/library/papers/30938088 | PubMed |
| 14 | 35923112 | The m6A methyltransferase Mettl3 deficiency attenuates hepatic stellate cell activation and liver fibrosis. | Mol Ther | 2022 | https://conductscience.org/library/papers/35923112 | PubMed |
| 15 | 32203053 | m6A-induced lncRNA MALAT1 aggravates renal fibrogenesis in obstructive nephropathy through the miR-145/FAK pathway. | Aging (Albany NY) | 2020 | https://conductscience.org/library/papers/32203053 | PubMed |
| 16 | 34111558 | m6A modification regulates lung fibroblast-to-myofibroblast transition through modulating KCNH6 mRNA translation. | Mol Ther | 2021 | https://conductscience.org/library/papers/34111558 | PubMed |
| 17 | 31705931 | SUMOylation homeostasis in tumorigenesis. | Cancer Lett | 2020 | https://conductscience.org/library/papers/31705931 | PubMed |
| 18 | 32483411 | SUMO1 modification of methyltransferase-like 3 promotes tumor progression via regulating Snail mRNA homeostasis in hepatocellular carcinoma. | Theranostics | 2020 | https://conductscience.org/library/papers/32483411 | PubMed |
| 19 | 29506078 | SUMOylation of the m6A-RNA methyltransferase METTL3 modulates its function. | Nucleic Acids Res | 2018 | https://conductscience.org/library/papers/29506078 | PubMed |
| 20 | 28521030 | HDOCK: a web server for protein-protein and protein-DNA/RNA docking based on a hybrid strategy. | Nucleic Acids Res | 2017 | https://conductscience.org/library/papers/28521030 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42957747
GET https://conductscience.org/api/papers/v1/42957747/authors?page=2